Action of quinolones on gene expression and bacterial membranes.
Dalhoff
A
A
Bayer AG, Pharma Research Center, Wuppertal, FRG.
Döring
G
G
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects*; D002939:Ciprofloxacin / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects*; D009643:Norfloxacin / Q000494:pharmacology; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000235:genetics; D011804:Quinolines / Q000494:pharmacology*; D013014:SOS Response, Genetics / Q000187:drug effects; D059005:Topoisomerase II Inhibitors
D000900:Anti-Bacterial Agents; D010078:Oxazines; D011804:Quinolines; D059005:Topoisomerase II Inhibitors; D002939:Ciprofloxacin; D015242:Ofloxacin; D009643:Norfloxacin